跳至主要内容
临床试验/ISRCTN65113000
ISRCTN65113000进行中(未招募)未知

What is the impact of a modified Roux-en-Y-gastric bypass operation on people with type 2 diabetes mellitus? The LONG LIMB-2 double-blinded randomised controlled clinical trial

Imperial College London0 个研究点目标入组 72 人开始时间: 2020年11月26日最近更新:

试验速览

阶段
未知
状态
进行中(未招募)
入组人数
72

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Diagnosis of type 2 diabetes mellitus (T2DM)
  • 2. Body Mass Index (BMI) >30 kg/m²
  • 3. Aged between 18 and 65 years
  • 4. Eligible for metabolic/bariatric surgery as per NICE guideline 189

排除标准

  • 1. Current use or need for insulin
  • 2. Unacceptably high risk for anaesthesia or surgery
  • 3. Pregnancy/breastfeeding
  • 4. Total small intestinal length <5.5 m

研究者

相似试验

已完成
Unknown
Effect of Weight Loss Following Roux-en-Y Gastric Bypass on Cancer Risk: A Mendelian Randomization StudyWeight LossRoux-en-Y Gastric BypassMendelian RandomizationCancer
JPRN-UMIN000052206Changzhou No.2 People&#39;s Hospital Affiliated to Nanjing Medical University
招募中
不适用
Additive effect of Roux-en Y Gastric Bypass to preoperative Very low calorie diet on non-alcoholic fatty liver diseases (NAFLD, NASH)-A randomized controlled trialK75.8E66.0Other specified inflammatory liver diseasesObesity due to excess calories
DRKS00027810Chirurgische Klinik Universitätsmedizin Mannheim150
进行中(未招募)
不适用
Comparison between the effects of Roux-en-Y gastric bypass (traditional surgery) and mini-gastric bypass (new technique) as treatments of morbid obesityC18.654.726.500Obesity
RBR-59k78kniversidade Estadual de Campinas
进行中(未招募)
1 期
Study of blood concentrations of morphine after oral administration of immediate release morphine in subject who have undergone a bariatric surgery called Roux-en-Y Gastric Bypass for a long time, in comparison with subjects who did not undergo surgery.
EUCTR2016-001143-40-FRTherapeutic Research Unit
招募中
不适用
The effects of the Laparoscopic Roux-en-Y Gastric Bypass and the Laparoscopic Mini Gastric Bypass on the remission of type 2 Diabetes Mellitus and the pathophysiological mechanisms that drive the conversion of malign to benign obesitytype 2 diabetes mellitus100184241001794310019654obesity
NL-OMON50364Academisch Medisch Centrum220